Upregulation of phosphorylated αB-crystallin in the brain of children and young adults with Down syndrome

Brain Research

Volumn 1268, Issue , 2009, Pages 162-173

  Palminiello, Sonia ^b   Jarzabek, Katarzyna ^b   Kaur, Kulbir ^b   Walus, Marius ^a   Rabe, Ausma ^a   Albertini, Giorgio ^b   Golabek, Adam A ^a   Kida, Elizabeth ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

B crystallin; Down syndrome; Ependymal injury; Phosphorylation

Indexed keywords

ALPHA CRYSTALLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; PHOSPHOPROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SERINE;

ADOLESCENT; ARTICLE; ASTROCYTE; CHILD; CONTROLLED STUDY; DOWN SYNDROME; EPENDYMA CELL; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFANT; MAJOR CLINICAL STUDY; OLIGODENDROGLIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STRESS; UPREGULATION; WHITE MATTER; ADULT; BRAIN; EPENDYMA; METABOLISM; PHOSPHORYLATION; PIA MATER;

ANIMALIA; MUS;

ADOLESCENT; ALPHA-CRYSTALLIN B CHAIN; ASTROCYTES; BRAIN; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; EPENDYMA; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFANT; OLIGODENDROGLIA; PHOSPHORYLATION; PIA MATER; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SERINE; UP-REGULATION; YOUNG ADULT;

EID: 64149115342     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.02.058     Document Type: Article

References (67)

1. Akeson E.C., Lambert J.P., Narayanswami S., Gardiner K., Bechtel L.J., and Davisson M.T. Ts65Dn - localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet. Cell Genet. 93 (2001) 270-276
2. Andley U.P. Crystallins in the eye: function and pathology. Prog. Retin Eye Res. 26 (2007) 78-98
3. Bhat S.P., and Nagineni C.N. αB subunit of lens-specific protein α-crystallin is present in other ocular and non-ocular tissues. Biochem. Biophys. Res. Commun. 158 (1989) 319-325
4. Braak H., Del Tredici K., Sandmann-Kiel D., Rüb U., and Schultz C. Nerve cells expressing heat-shock proteins in Parkinson's disease. Acta Neuropathol. 102 (2001) 449-454
5. Cairns N.J. Molecular neuropathology of transgenic mouse models of Down syndrome. J. Neural Transm., Suppl. 61 (2001) 289-301
6. Chrast R., Scott H.S., Papasavvas M.P., Rossier C., Antonarakis E.S., Barras C., Davisson M.T., Schmidt C., Estivill X., Dierssen M., Pritchard M., and Antonarakis S.E. The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res. 10 (2000) 2006-2021
7. Contestabile A., Fila T., Ceccarelli C., Bonasoni P., Bonapace L., Santini D., Bartesaghi R., and Ciani E. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17 (2007) 665-678
8. Dabir D.V., Trojanowski J.Q., Richter-Landsberg C., Lee V.M., and Forman M.S. Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. Am. J. Pathol. 64 (2004) 155-166
9. Davisson M.T., Schmidt C., and Akeson E.C. Segmental trisomy for murine chromosome 16: a new system for studying Down syndrome. In: Patterson D., and Epstein C.J. (Eds). Molecular Genetics of Chromosome 21 and Down Syndrome (1990), Wiley-Liss, New York 263-280
10. den Engelsman J., Keijsers V., de Jong W.W., and Boelens W.C. The small heat-shock protein αB-crystallin promotes FBX4-dependent ubiquitination. J. Biol. Chem. 278 (2003) 4699-4704
11. den Engelsman J., Bennink E.J., Doerwald L., Onnekink C., Wunderink L., Andley U.P., Kato K., de Jong W.W., and Boelens W.C. Mimicking phosphorylation of the small heat-shock protein αB-crystallin recruits the F-box protein FBX4 to nuclear SC35 speckles. Eur. J. Biochem. 271 (2004) 4195-4203
12. den Engelsman J., Gerrits D., de Jong W.W., Robbins J., Kato K., and Boelens W.C. Nuclear import of αB-crystallin is phosphorylation-dependent and hampered by hyperphosphorylation of the myopathy-related mutant R120G. J. Biol. Chem. 280 (2005) 37139-371348
13. Djabali K., de Néchaud B., Landon F., and Portier M.M. αB-crystallin interacts with intermediate filaments in response to stress. J. Cell. Sci. 110 (1997) 2759-2769
14. Djabali K., Piron G., de Néchaud B., and Portier M.M. αB-crystallin interacts with cytoplasmic intermediate filament bundles during mitosis. Exp. Cell Res. 253 (1999) 649-662
15. Ecroyd H., Meehan S., Horwitz J., Aquilina J.A., Benesch J.L., Robinson C.V., Macphee C.E., and Carver J.A. Mimicking phosphorylation of αB-crystallin affects its chaperone activity. Biochem. J. 401 (2007) 129-141
16. Engidawork E., and Lubec G. Molecular changes in fetal Down syndrome brain. J. Neurochem. 84 (2003) 895-904
17. Epstein C.J. Down syndrome. In: Scriver C.R. (Ed). The Metabolic and Molecular Bases of Inherited Disease (1995), Mc Graw-Hill, New York 749-794
18. FitzPatrick D.R., Ramsay J., McGill N.I., Shade M., Carothers A.D., and Hastie N.D. Transcriptome analysis of human autosomal trisomy. Hum. Mol. Genet 11 (2002) 3249-3256
19. Galdzicki Z., and Siarey R.J. Understanding mental retardation in Down's syndrome using trisomy 16 mouse models. Genes Brain Behav. 2 (2003) 167-178
20. Gardiner K. Predicting pathway perturbations in Down syndrome. J. Neural Transm., Suppl. 67 (2003) 21-37
21. Gitton Y., Dahmane N., Baik S., Ruiz i Altaba A., Neidhardt L., Scholze M., Herrmann B.G., Kahlem P., Benkahla A., Schrinner S., Yildirimman R., Herwig R., Lehrach H., and Yaspo M.L. HSA21 expression map initiative. A gene expression map of human chromosome 21 orthologues in the mouse. Nature 420 (2002) 586-590
22. Golabek A.A., Kida E., Walus M., Wujek P., Mehta P., and Wisniewski K.E. Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I. J. Biol. Chem. 278 (2003) 7135-7145
23. Guidi S., Bonasoni P., Ceccarelli C., Santini D., Gualtieri F., Ciani E., and Bartesaghi R. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol. 18 (2008) 180-197
24. Hart I.K., Richardson W.D., Heldin C.H., Westermark B., and Raff M.C. PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage. Development 105 (1989) 595-603
25. Horwitz J. α-Crystallin can function as a molecular chaperone. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10449-10453
26. Ito H., Okamoto K., Nakayama H., Isobe T., and Kato K. Phosphorylation of αB-crystallin in response to various types of stress. J. Biol. Chem. 47 (1997) 29934-29941
27. Ito H., Kamei K., Iwamoto I., Inaguma Y., Nohara D., and Kato K. Phosphorylation-induced change of the oligomerization state of αB-crystallin. J. Biol. Chem. 276 (2001) 5346-5352
28. Iwaki T., Kume-Iwaki A., Liem R.K.H., and Goldman J.E. αB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 57 (1989) 71-78
29. Iwaki T., Kume-Iwaki A., and Goldman J.E. Cellular distribution of αB-crystallin in non-lenticular tissues. J. Histochem. Cytochem. 38 (1990) 31-39
30. Iwaki T., Iwaki A., Miyazono M., and Goldman J.E. Preferential expression of αB-crystallin in astrocytic elements of neuroectodermal tumors. Cancer 68 (1991) 2230-24240
31. Iwaki T., Wisniewski T., Iwaki A., Corbin E., Tomokane N., Teteishi J., and Goldman J.E. Accumulation of αB-crystallin in central nervous system glia and neurons in pathologic conditions. Am. J. Pathol. 140 (1992) 345-356
32. Jackson E.L., Garcia-Verdugo J.M., Gil-Perotin S., Roy M., Quinones-Hinojosa A., VandenBerg S., and Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51 (2006) 187-199
33. Kamradt M.C., Chen F., and Cryns V.L. The small heat shock protein αB-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J. Biol. Chem. 276 (2001) 16059-16063
34. Kato S., Hirano A., Umahara T., Kato M., Herz F., and Ohama E. Comparative immunohistochemical study on the expression of alpha B crystallin, ubiquitin and stress-response protein 27 in ballooned neurons in various disorders. Neuropathol. Appl. Neurobiol. 18 (1992) 335-340
35. Kato K., Ito H., Kamei K., Inaguma Y., Iwamoto I., and Saga S. Phosphorylation of αB-crystallin in mitotic cells and identification of enzymatic activities responsible for phosphorylation. J. Biol. Chem. 273 (1998) 28346-28354
36. Kato K., Inaguma Y., Ito H., Iida K., Iwamoto I., Kamei K., Ochi N., Ohta H., and Kishikawa M. Ser-59 is the major phosphorylation site in αB-crystallin accumulated in the brains of patients with Alexander's disease. J. Neurochem. 76 (2001) 730-736
37. Klemenz R., Fröhli E., Steiger R.H., Schäfer R., and Aoyama A. αB-Crystallin is a small heat shock protein. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3652-3656
38. Launay N., Goudeau B., Kato K., Vicart P., and Lilienbaum A. Cell signaling pathways to αB-crystallin following stresses of the cytoskeleton. Exp. Cell Res. 312 (2006) 3570-3584
39. Lin D.I., Barbash O., Kumar K.G., Weber J.D., Harper J.W., Klein-Szanto A.J., Rustgi A., Fuchs S.Y., and Diehl J.A. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol. Cell 24 (2006) 355-366
40. Lowe J., Errington D.R., Lennox G., Pike I., Spendlove I., Landon M., and Mayer R.J. Ballooned neurons in several neurodegenerative diseases and stroke contain αB crystallin. Neuropathol. Appl. Neurobiol. 18 (1992) 341-350
41. Maddala R., and Rao V.P. αB-crystallin localizes to the leading edges of migrating lens epithelial cells. Exp. Cell Res. 306 (2005) 203-215
42. Maeda Y., Solanky M., Menonna J., Chapin J., Li W., and Dowling P. Platelet-derived growth factor-α receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann. Neurol. 49 (2001) 776-785
43. Mao R., Wang X., Spitznagel Jr. E.L., Frelin L.P., Ting J.C., Ding H., Kim J.W., Ruczinski I., Downey T.J., and Pevsner J. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol. 6 (2005) R107
44. McTigue D.M., and Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem 107 (2008) 1-19
45. Mehlen P., Preville X., Chareyron P., Briolay J., Klemenz R., and Arrigo A.P. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J. Immunol. 154 (1995) 363-374
46. Mehlen P., Schulze-Osthoff K., and Arrigo A.P. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J. Biol. Chem. 271 (1996) 16510-16514
47. Morrison L.E., Hoover H.E., Thuerauf D.J., and Glembotski C.C. Mimicking phosphorylation of αB-crystallin on serine-59 is necessary and sufficient to provide maximal protection of cardiac myocytes from apoptosis. Circ. Res. 92 (2003) 203-211
48. Mutton D., Alberman E., and Hook E.B. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down syndrome cytogenetic register and the association of clinical cytogeneticists. J. Med. Genet. 33 (1996) 387-394
49. Nishiyama A., Lin X.H., Giese N., Heldin C.H., and Stallcup W.B. Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J. Neurosci. Res. 43 (1996) 299-314
50. Palminiello S., Kida E., Kaur K., Walus M., Wisniewski K.E., Wierzba-Bobrowicz T., Rabe A., Albertini G., and Golabek A.A. Increased levels of carbonic anhydrase II in the developing Down syndrome brain. Brain Res. 1190 (2008) 193-205
51. Pantoni L., Garcia J.H., and Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke 27 (1996) 1641-1646
52. Pountney D.L., Treweek T.M., Chataway T., Huang Y., Chegini F., Blumbergs P.C., Raftery M.J., and Gai W.P. Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. Neurotox. Res. 7 (2005) 77-85
53. Rachidi M., and Lopes C. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways. Eur. J. Paediatr. Neurol. 12 (2008) 168-182
54. Reddy G.B., Kumar P.A., and Kumar M.S. Chaperone-like activity and hydrophobicity of α-crystallin. IUBMB Life 58 (2006) 632-641
55. Renkawek K., deJong W.W., Merck K.B., Frenken C.W.G.M., vanWorkum F.P.A., and Bosman G.J.C.G.M. αB crystalline is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropathol. (Berl) 83 (1992) 324-327
56. Robinson M.L., and Overbeekm P.A. Differential expression of alpha A- and alpha B-crystallin during murine ocular development. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2276-2284
57. Shinohara H., Inaguma Y., Goto S., Inagaki T., and Kato K. αB crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J. Neurol. Sci. 119 (1993) 203-208
58. Simpson J.E., Fernando M.S., Clark L., Ince P.G., Matthews F., Forster G., O'Brien J.T., Barber R., Kalaria R.N., Brayne C., Shaw P.J., Lewis C.E., Wharton S.B., and MRC Cognitive Function and Ageing Neuropathology Study Group. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol. Appl. Neurobiol. 33 (2007) 410-419
59. Spassky N., Merkle F.T., Flames N., Tramontin A.D., Garcia-Verdugo J.M., and Alvarez-Buylla A. Adult ependymal cells are postmitotic and derived from radial glia cells during embryogenesis. J. Neurosci. 25 (2005) 10-18
60. Sun Y., and MacRae T.H. The small heat shock proteins and their role in human disease. FEBS J. 272 (2005) 2613-2627
61. Swatton J.E., Sellers L.A., Faull R.L.M., Holland A., Iritani S., and Bahn S. Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. Eur. J. Neurosci. 19 (2004) 2711-2719
62. Vercauteren F.G.G., Bergeron J.J.M., Vandesande F., Arckens L., and Quirion R. Proteomic approaches in brain research and neuropharmacology. Eur. J. Pharmacol. 500 (2004) 385-398
63. Vicart P., Caron A., Guicheney P., Li Z., Prévost M.-C., Faure A., Chateau D., Chapon F., Tomé F., Dupret J.-M., Paulin D., and Fardeau M. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nature 20 (1998) 92-95
64. Wang K., and Spector A. α-crystallin stabilizes actin filaments and prevents cytochalasin-induced depolymerization in a phosphorylation-dependent manner. Eur. J. Biochem. 242 (1996) 56-66
65. Wisniewski K.E., Kida E., Golabek A.A., Walus M., Rabe A., Palminiello S., and Albertini G. Down syndrome: from pathology to pathogenesis. In: Rondal J.A., and Perera J. (Eds). Down syndrome. Neurobehavioural Specificity (2006), John Wiley and Sons, Chichester 17-33
66. Xi J.H., Bai F., McGaha R., and Andley U.P. Alpha-crystallin expression affects microtubule assembly and prevents their aggregation. FASEB J. 20 (2006) 846-857
67. Zana M., Janka Z., and Kálmán J. Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease. Neurobiol. Aging 28 (2007) 648-676